Virtus ETF Advisers LLC Bio Atla, Inc. Transaction History

Virtus ETF Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.13 - $5.38 $15,921 - $40,215	-7,475 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.38 - $18.78 $1,914 - $8,206	-437 Reduced 5.52%	7,475 $37,000
Q4 2021 Feb 14, 2022	BUY	$19.0 - $30.95 $49,096 - $79,974	2,584 Added 48.5%	7,912 $155,000
Q3 2021 Nov 15, 2021	SELL	$29.44 - $43.74 $8,096 - $12,028	-275 Reduced 4.91%	5,328 $157,000
Q2 2021 Aug 10, 2021	BUY	$38.07 - $56.17 $213,306 - $314,720	5,603 New	5,603 $237,000

17.4M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $22.5M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.